European perspective on biosimilars

被引：0
|
作者：
Wadhwa, Meenu [1 ]
Thorpe, Robin [1 ]
机构：
[1] NIBSC, Biotherapeut Grp, Potters Bar EN6 3QG, Herts, England
来源：
BIOANALYSIS | 2013年 / 5卷 / 05期
关键词：
comparability; global development; immunogenicity; reference product; reference standards; terminology; WHO; EFFICACY; SAFETY;
D O I：
10.4155/BIO.13.2
中图分类号：
Q5 [生物化学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：521 / 524
页数：4
相关论文
共 50 条
  • [41] Biologics and biosimilars: a legal perspective from Canada
    Furlanetto, Angela
    Purcell, Nikolas
    PHARMACEUTICAL PATENT ANALYST, 2016, 5 (02) : 79 - 81
  • [42] Biosimilars: A consideration of the regulations in the United States and European union
    Daller, Justin
    REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2016, 76 : 199 - 208
  • [43] BIOSIMILARS: POTENTIAL CLINICAL DIFFERENCES AND EUROPEAN REGULATORY ASPECTS
    Esplugues Mota, J. V.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 7 - 8
  • [44] European legislation on biosimilars: recommendations of the EMEA regarding quality
    Prugnaud, J. -L.
    NEPHROLOGIE & THERAPEUTIQUE, 2009, 5 : 3 - 5
  • [45] European biosimilars conference highlights extrapolation as key issue
    Derbyshire, Michelle
    GABI JOURNAL-GENERICS AND BIOSIMILARS INITIATIVE JOURNAL, 2015, 4 (03): : 149 - +
  • [46] Emerging Insights into European Markets of Biologics, Including Biosimilars
    Simoens, Steven
    Huys, Isabelle
    PHARMACEUTICALS, 2022, 15 (05)
  • [47] Pricing and Reimbursement of Biosimilars in Central and Eastern European Countries
    Kawalec, Pawel
    Stawowczyk, Ewa
    Tesar, Tomas
    Skoupa, Jana
    Turcu-Stiolica, Adina
    Dimitrova, Maria
    Petrova, Guenka I.
    Rugaja, Zinta
    Mannik, Agnes
    Harsanyi, Andras
    Draganic, Pero
    FRONTIERS IN PHARMACOLOGY, 2017, 8
  • [48] DIFFERENCES IN BIOSIMILARS APPROVAL BETWEEN THE USA AND EUROPEAN UNION
    Franco, Benjamin
    Banacu, Silviu-Cristian
    MANAGEMENT RESEARCH AND PRACTICE, 2021, 13 (04): : 5 - 16
  • [49] A wide angle view of biosimilars from a bioanalytical perspective
    Oldfield, Philip
    BIOANALYSIS, 2013, 5 (05) : 533 - 535
  • [50] Japanese regulatory authority's perspective on biosimilars reply
    Bennett, Charles L.
    Chen, Brian
    Hermanson, Terhi
    Georgantopoulos, Peter
    Sartor, Oliver A.
    LANCET ONCOLOGY, 2015, 16 (03): : E102 - E102
12345